Cargando…
Determining the utility of diagnostic genomics: a conceptual framework
BACKGROUND: Diagnostic efficacy is now well established for diagnostic genomic testing in rare disease. Assessment of overall utility is emerging as a key next step, however ambiguity in the conceptualisation and measurement of utility has impeded its assessment in a comprehensive manner. We propose...
Autores principales: | Mallett, Andrew, Stark, Zornitza, Fehlberg, Zoe, Best, Stephanie, Goranitis, Ilias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433656/ https://www.ncbi.nlm.nih.gov/pubmed/37587497 http://dx.doi.org/10.1186/s40246-023-00524-1 |
Ejemplares similares
-
The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments
por: Goranitis, Ilias, et al.
Publicado: (2020) -
Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia
por: Mordaunt, Dylan A, et al.
Publicado: (2023) -
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
por: Jayasinghe, Kushani, et al.
Publicado: (2021) -
Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia
por: Mordaunt, Dylan A., et al.
Publicado: (2023) -
A conceptual framework for consciousness
por: Graziano, Michael S. A.
Publicado: (2022)